ELIZABETH GALLANT: Open Payments
NPI 1861109597 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 18 payments from 10 companies in 2025. Trend: 2023 $531 · 2024 $636 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $81 |
| ABIOMED | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Amgen Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| HEARTFLOW, INC. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VYNDAQEL, LEQVIO, Repatha, JARDIANCE, Attruby, FUROSCIX, AMVUTTRA, FFRct.
Industry payments across MA — which companies pay providers there.
